Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Prompt Payment of Health Benefits Claims Act of 2006
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
S. 2664 Pharmacy Access Improvement (PhAIM) Act of 2006 S. 2551 Prompt Payment of Health Benefits Claims Act of 2006 S. 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 Implementation of the Deficit Reduction Act of 2005 - Pharmacy Reimbursement Implementation of Medicare Part D CMS 1270-P re: Durable Medical Equipment Competitive Bidding Program – CMS-4119-P re: proposing to allow the Secretary of the DHHS to share Part D claims data for research, analysis, reporting, and public health functions CMS re: Draft 2007 Coordination of Benefits Guidance Medicare Part B payment reforms. H.R. 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006
Pharmacist Access and Recognition in Medicare (PHARM) Act of 2006
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2006 · year_end · YY
S. 2664 Pharmacy Access Improvement (PhAIM) Act of 2006 S. 2551 Prompt Payment of Health Benefits Claims Act of 2006 S. 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 Implementation of the Deficit Reduction Act of 2005 - Pharmacy Reimbursement Implementation of Medicare Part D CMS 1270-P re: Durable Medical Equipment Competitive Bidding Program – CMS-4119-P re: proposing to allow the Secretary of the DHHS to share Part D claims data for research, analysis, reporting, and public health functions CMS re: Draft 2007 Coordination of Benefits Guidance Medicare Part B payment reforms. H.R. 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006
Source: Senate LDA
S. 2664 Pharmacy Access Improvement (PhAIM) Act of 2006 S. 2551 Prompt Payment of Health Benefits Claims Act of 2006 S. 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 Implementation of the Deficit Reduction Act of 2005 - Pharmacy Reimbursement Implementation of Medicare Part D CMS 1270-P re: Durable Medical Equipment Competitive Bidding Program – CMS-4119-P re: proposing to allow the Secretary of the DHHS to share Part D claims data for research, analysis, reporting, and public health functions CMS re: Draft 2007 Coordination of Benefits Guidance Medicare Part B payment reforms. H.R. 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006
Pharmacy Access Improvement (PhAIm) Act of 2006
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
S. 2664 Pharmacy Access Improvement (PhAIM) Act of 2006 S. 2551 Prompt Payment of Health Benefits Claims Act of 2006 S. 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 Implementation of the Deficit Reduction Act of 2005 - Pharmacy Reimbursement Implementation of Medicare Part D CMS 1270-P re: Durable Medical Equipment Competitive Bidding Program – CMS-4119-P re: proposing to allow the Secretary of the DHHS to share Part D claims data for research, analysis, reporting, and public health functions CMS re: Draft 2007 Coordination of Benefits Guidance Medicare Part B payment reforms. H.R. 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006
Pharmaceutical Market Access and Drug Safety Act of 2005
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
H.R. 1652 Access to Legal Pharmaceuticals Act H.R. 1808 Safe Online Drug Act of 2005 H.R. 1815 National Defense Authorization Act for Fiscal Year 2006 – Pharmacy Program H.R. 4769 Prescription Drug Abuse Elimination Act of 2006 H.R. 5122 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program H.R. 5280 Dextromethorphan Distribution Act of 2006 H.R. 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 – Prescription Drug Importation H.R. 5441 Department of Homeland Security Appropriations Act, 2007 – Prescription Drug Importation S. 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S. 778 Pharmacy Consumer Protection Act of 2005 S. 809 Access to Legal Pharmaceuticals Act S. 2766 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program S. 3807 Enhancing Drug Safety and Innovation Act of 2006 S. 3546 Dietary Supplement and Nonprescription Drug Consumer Protection Act Pharmacy Compounding Counterfeit Drugs Health Information Technology Implementation of the Combat Methamphetamine Epidemic Act of 2005 FDA Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act (PDMA) FDA Docket No. 2006N-0283 re: the proposed survey of physicians’ perceptions on the impact of early risk communication about medical products DEA Docket No. DEA-2911 re: retail sales of scheduled listed chemical products and self-certification of regulated sellers of scheduled listed chemical products CMS-1321-P re: proposed revisions to the payment policies under the physician fee schedule for calendar year 2007 DEA-287N re the issuing of multiple prescriptions for Schedule II Controlled Substances FDA Re: Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act Proposed revisions to the United States Pharmacopeia (USP) General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. H.R. 1539 A bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions, and for other purposes.
Dietary Supplement and Nonprescription Drug Consumer Protection Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
H.R. 1652 Access to Legal Pharmaceuticals Act H.R. 1808 Safe Online Drug Act of 2005 H.R. 1815 National Defense Authorization Act for Fiscal Year 2006 – Pharmacy Program H.R. 4769 Prescription Drug Abuse Elimination Act of 2006 H.R. 5122 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program H.R. 5280 Dextromethorphan Distribution Act of 2006 H.R. 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 – Prescription Drug Importation H.R. 5441 Department of Homeland Security Appropriations Act, 2007 – Prescription Drug Importation S. 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S. 778 Pharmacy Consumer Protection Act of 2005 S. 809 Access to Legal Pharmaceuticals Act S. 2766 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program S. 3807 Enhancing Drug Safety and Innovation Act of 2006 S. 3546 Dietary Supplement and Nonprescription Drug Consumer Protection Act Pharmacy Compounding Counterfeit Drugs Health Information Technology Implementation of the Combat Methamphetamine Epidemic Act of 2005 FDA Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act (PDMA) FDA Docket No. 2006N-0283 re: the proposed survey of physicians’ perceptions on the impact of early risk communication about medical products DEA Docket No. DEA-2911 re: retail sales of scheduled listed chemical products and self-certification of regulated sellers of scheduled listed chemical products CMS-1321-P re: proposed revisions to the payment policies under the physician fee schedule for calendar year 2007 DEA-287N re the issuing of multiple prescriptions for Schedule II Controlled Substances FDA Re: Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act Proposed revisions to the United States Pharmacopeia (USP) General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. H.R. 1539 A bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions, and for other purposes.
District of Columbia Appropriations Act, 2007
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
S. 3708 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007 – General Health Agency Funding S. 3660 District of Columbia Appropriations Act, 2007 H.R. 5647 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropraitions Act, 2007 - General Health Agency Funding
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
S. 3708 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007 – General Health Agency Funding S. 3660 District of Columbia Appropriations Act, 2007 H.R. 5647 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropraitions Act, 2007 - General Health Agency Funding
Enhancing Drug Safety and Innovation Act of 2006
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
H.R. 1652 Access to Legal Pharmaceuticals Act H.R. 1808 Safe Online Drug Act of 2005 H.R. 1815 National Defense Authorization Act for Fiscal Year 2006 – Pharmacy Program H.R. 4769 Prescription Drug Abuse Elimination Act of 2006 H.R. 5122 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program H.R. 5280 Dextromethorphan Distribution Act of 2006 H.R. 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 – Prescription Drug Importation H.R. 5441 Department of Homeland Security Appropriations Act, 2007 – Prescription Drug Importation S. 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S. 778 Pharmacy Consumer Protection Act of 2005 S. 809 Access to Legal Pharmaceuticals Act S. 2766 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program S. 3807 Enhancing Drug Safety and Innovation Act of 2006 S. 3546 Dietary Supplement and Nonprescription Drug Consumer Protection Act Pharmacy Compounding Counterfeit Drugs Health Information Technology Implementation of the Combat Methamphetamine Epidemic Act of 2005 FDA Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act (PDMA) FDA Docket No. 2006N-0283 re: the proposed survey of physicians’ perceptions on the impact of early risk communication about medical products DEA Docket No. DEA-2911 re: retail sales of scheduled listed chemical products and self-certification of regulated sellers of scheduled listed chemical products CMS-1321-P re: proposed revisions to the payment policies under the physician fee schedule for calendar year 2007 DEA-287N re the issuing of multiple prescriptions for Schedule II Controlled Substances FDA Re: Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act Proposed revisions to the United States Pharmacopeia (USP) General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. H.R. 1539 A bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions, and for other purposes.
Pharmacy Consumer Protection Act of 2005
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
H.R. 1652 Access to Legal Pharmaceuticals Act H.R. 1808 Safe Online Drug Act of 2005 H.R. 1815 National Defense Authorization Act for Fiscal Year 2006 – Pharmacy Program H.R. 4769 Prescription Drug Abuse Elimination Act of 2006 H.R. 5122 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program H.R. 5280 Dextromethorphan Distribution Act of 2006 H.R. 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 – Prescription Drug Importation H.R. 5441 Department of Homeland Security Appropriations Act, 2007 – Prescription Drug Importation S. 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S. 778 Pharmacy Consumer Protection Act of 2005 S. 809 Access to Legal Pharmaceuticals Act S. 2766 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program S. 3807 Enhancing Drug Safety and Innovation Act of 2006 S. 3546 Dietary Supplement and Nonprescription Drug Consumer Protection Act Pharmacy Compounding Counterfeit Drugs Health Information Technology Implementation of the Combat Methamphetamine Epidemic Act of 2005 FDA Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act (PDMA) FDA Docket No. 2006N-0283 re: the proposed survey of physicians’ perceptions on the impact of early risk communication about medical products DEA Docket No. DEA-2911 re: retail sales of scheduled listed chemical products and self-certification of regulated sellers of scheduled listed chemical products CMS-1321-P re: proposed revisions to the payment policies under the physician fee schedule for calendar year 2007 DEA-287N re the issuing of multiple prescriptions for Schedule II Controlled Substances FDA Re: Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act Proposed revisions to the United States Pharmacopeia (USP) General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. H.R. 1539 A bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions, and for other purposes.
Access to Legal Pharmaceuticals Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
H.R. 1652 Access to Legal Pharmaceuticals Act H.R. 1808 Safe Online Drug Act of 2005 H.R. 1815 National Defense Authorization Act for Fiscal Year 2006 – Pharmacy Program H.R. 4769 Prescription Drug Abuse Elimination Act of 2006 H.R. 5122 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program H.R. 5280 Dextromethorphan Distribution Act of 2006 H.R. 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 – Prescription Drug Importation H.R. 5441 Department of Homeland Security Appropriations Act, 2007 – Prescription Drug Importation S. 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S. 778 Pharmacy Consumer Protection Act of 2005 S. 809 Access to Legal Pharmaceuticals Act S. 2766 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program S. 3807 Enhancing Drug Safety and Innovation Act of 2006 S. 3546 Dietary Supplement and Nonprescription Drug Consumer Protection Act Pharmacy Compounding Counterfeit Drugs Health Information Technology Implementation of the Combat Methamphetamine Epidemic Act of 2005 FDA Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act (PDMA) FDA Docket No. 2006N-0283 re: the proposed survey of physicians’ perceptions on the impact of early risk communication about medical products DEA Docket No. DEA-2911 re: retail sales of scheduled listed chemical products and self-certification of regulated sellers of scheduled listed chemical products CMS-1321-P re: proposed revisions to the payment policies under the physician fee schedule for calendar year 2007 DEA-287N re the issuing of multiple prescriptions for Schedule II Controlled Substances FDA Re: Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act Proposed revisions to the United States Pharmacopeia (USP) General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. H.R. 1539 A bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions, and for other purposes.
Homeland Emergency Responders Organization Act of 2002
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
H.R. 1652 Access to Legal Pharmaceuticals Act H.R. 1808 Safe Online Drug Act of 2005 H.R. 1815 National Defense Authorization Act for Fiscal Year 2006 – Pharmacy Program H.R. 4769 Prescription Drug Abuse Elimination Act of 2006 H.R. 5122 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program H.R. 5280 Dextromethorphan Distribution Act of 2006 H.R. 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 – Prescription Drug Importation H.R. 5441 Department of Homeland Security Appropriations Act, 2007 – Prescription Drug Importation S. 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S. 778 Pharmacy Consumer Protection Act of 2005 S. 809 Access to Legal Pharmaceuticals Act S. 2766 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program S. 3807 Enhancing Drug Safety and Innovation Act of 2006 S. 3546 Dietary Supplement and Nonprescription Drug Consumer Protection Act Pharmacy Compounding Counterfeit Drugs Health Information Technology Implementation of the Combat Methamphetamine Epidemic Act of 2005 FDA Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act (PDMA) FDA Docket No. 2006N-0283 re: the proposed survey of physicians’ perceptions on the impact of early risk communication about medical products DEA Docket No. DEA-2911 re: retail sales of scheduled listed chemical products and self-certification of regulated sellers of scheduled listed chemical products CMS-1321-P re: proposed revisions to the payment policies under the physician fee schedule for calendar year 2007 DEA-287N re the issuing of multiple prescriptions for Schedule II Controlled Substances FDA Re: Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act Proposed revisions to the United States Pharmacopeia (USP) General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. H.R. 1539 A bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions, and for other purposes.
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
S. 3708 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007 – General Health Agency Funding S. 3660 District of Columbia Appropriations Act, 2007 H.R. 5647 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropraitions Act, 2007 - General Health Agency Funding
H.R. 1652 Access to Legal Pharmaceuticals Act H.R. 1808 Safe Online Drug Act of 2005 H.R. 1815 National Defense Authorization Act for Fiscal Year 2006 – Pharmacy Program H.R. 4769 Prescription Drug Abuse Elimination Act of 2006 H.R. 5122 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program H.R. 5280 Dextromethorphan Distribution Act of 2006 H.R. 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 – Prescription Drug Importation H.R. 5441 Department of Homeland Security Appropriations Act, 2007 – Prescription Drug Importation S. 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S. 778 Pharmacy Consumer Protection Act of 2005 S. 809 Access to Legal Pharmaceuticals Act S. 2766 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program S. 3807 Enhancing Drug Safety and Innovation Act of 2006 S. 3546 Dietary Supplement and Nonprescription Drug Consumer Protection Act Pharmacy Compounding Counterfeit Drugs Health Information Technology Implementation of the Combat Methamphetamine Epidemic Act of 2005 FDA Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act (PDMA) FDA Docket No. 2006N-0283 re: the proposed survey of physicians’ perceptions on the impact of early risk communication about medical products DEA Docket No. DEA-2911 re: retail sales of scheduled listed chemical products and self-certification of regulated sellers of scheduled listed chemical products CMS-1321-P re: proposed revisions to the payment policies under the physician fee schedule for calendar year 2007 DEA-287N re the issuing of multiple prescriptions for Schedule II Controlled Substances FDA Re: Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act Proposed revisions to the United States Pharmacopeia (USP) General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. H.R. 1539 A bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions, and for other purposes.
H.R.2841 Medicare Safe Needle Disposal Coverage Act of 2005 H.R. 6111 An act to amend the Internal Revenue Code of 1986 to extend expiring provisions, and for other purposes – Vaccine Reimbursement H.R. 6164 National Institutes of Health Reform Act of 2006 H.R. 1020 National Pain Care Policy Act of 2005
S. 3708 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007 – General Health Agency Funding S. 3660 District of Columbia Appropriations Act, 2007 H.R. 5647 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropraitions Act, 2007 - General Health Agency Funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2005 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2004 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2003 · year_end · YY
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2002 · year_end · YY
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2001 · year_end · YY
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, White House Office